CVS Pharmacy emblem is noticed in Washington DC, United States on July 9, 2024. Jakub Porzycki | Nurphoto | Getty ImagesCVS Well being’s board has engaged advisors to behavior a strategic evaluation of its trade, in line with other folks aware of the subject, as the corporate contends with doable activist force and a seriously depressed inventory value. The evaluation has been ongoing for a while, mentioned the folks, however there is not any simple task on what movements, if any, the corporate will take.CVS control, together with CEO Karen Lynch, met with main shareholder Glenview Capital Monday to talk about the corporate’s lagging potentialities and Glenview’s plans to restore the inventory, CNBC up to now reported.However Lynch has to cope with an insurance coverage trade hammered through heightened clinical prices.In a observation, CVS spokesman David Whitrap informed CNBC: “CVS Well being’s control crew and Board of Administrators are frequently exploring techniques to create shareholder price. We stay concerned about riding efficiency and turning in top of the range healthcare services and products enabled through our unequalled scale and built-in type.”The corporate has additionally grappled with management turnover. Lynch assumed direct management of CVS’s insurance coverage unit previous this yr, displacing then-president Brian Kane.CVS stocks rose round 2.5% in after-hours buying and selling Monday at the information, which used to be first reported through Reuters.— CNBC’s Bertha Coombs contributed to this tale
